Certificate number:RU.77.99.11.003.Е.003829.08.17
Date of registration and renewal:30.08.2017
Dosage form: & nbspChewable tablets weighing 1740 mg ± 5%
Classification "Composition" & nbsp Dietary supplements - proteins, amino acids and their derivatives Supplements - vitamins, vitamin-like substances and coenzymes Supplements - macro and microelements
Classification "Clinical" & nbsp Supplements containing zinc, copper, manganese Supplements containing calcium and phosphorus Supplements containing iodine
Composition: & nbspBrown sugar, calcium phosphate, citric acid, vitamin C, magnesium oxide, niacinamide, magnesium salt of stearic acid, silicon dioxide, iron fumarate, microcrystalline cellulose, vitamin E acetate, steric acid, natural flavor of orange (maltodextrin, natural orange flavor, citric acid Butyl hydroxytoluene), zinc oxide, vitamin B6 (pyridoxine hydrochloride), vitamin B2 (riboflavin), vitamin B5 (calcium pantothenate), vitamin B1 (thiamine mononitrate), vitamin A acetate, folic acid, vitamin D3 lekaltsiferol), manganese sulfate, biotin, natural flavor of pineapple (dextrose, natural flavor of pineapple, silica), vitamin K1 (phytomenadione), basic copper carbonate, potassium iodide, iron oxide yellow, vitamin B12 (cyanocobalamin).
Scope: & nbspTo provide the population with a supplementary source of vitamins A, D3, E, C, B1, B2, B3 (niacinamide), B5 (pantothenic acid), B6, B12, folic acid, biotin,mineral substances: magnesium, iron, zinc, copper, manganese, iodine; containing calcium, vitamin K1.
Suggested Usage: & nbspChildren from 7 to 14 years on 1 chewing tablet per day with meals. Duration of admission is 2-3 weeks. If necessary, the reception can be repeated in a month.
Contraindications:Individual intolerance of the components of the product, violation of carbohydrate metabolism. Before use, consult a pediatrician. Children with thyroid disorders should consult an endocrinologist.
Shelf life:2 years.
Storage conditions:Store in a place inaccessible to children at a temperature of 15 ° C to 25 ° C and at a relative humidity of not more than 60%.
Research protocols:In exchange for the certificate of state registration No. RU.77.99.11.003.Е.003499.08.17 of 04.08.2017, the expert opinion of the FBU of the Federal Service for Supervision of Consumer Rights Protection and Trade of Rospotrebnadzor № 10-2ФЦ / 2734 of 21.07.2017.
Recipient:Takeda Pharmaceuticals, LLCTakeda Pharmaceuticals, LLC Russian Federation
Information update date: & nbsp26.11.2017
Instructions
Up